World's Best Scientists 2026 revealed!
Regulatory Toxicology and Pharmacology
H-index 30

Regulatory Toxicology and Pharmacology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1987 33 65 13

Additional Metrics

Number of Best Scientists*: 155
Documents by Best Scientists*: 210
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 131
SCIMAGO SJR: 0.944
Impact Factor: 3.5

Overview

Top Research Topics at Regulatory Toxicology and Pharmacology?

Regulatory Toxicology and Pharmacology was organized to reinforce research efforts on Toxicity, Risk assessment, Toxicology, Pharmacology and Internal medicine. The studies on Toxicity discussed can also contribute to research in the domains of Physiology and Carcinogen. The Risk assessment works featured in Regulatory Toxicology and Pharmacology incorporate elements from Risk analysis (engineering), Risk management and Environmental exposure, Environmental health.

The studies tackled, which mainly focus on Pharmacology, apply to In vivo as well. The work tackled in it goes beyond the discipline of Internal medicine as it also encompasses Endocrinology. The research on Genotoxicity discussed in Regulatory Toxicology and Pharmacology draws on the closely related field of Micronucleus test.

  • Toxicity (20.00%)
  • Risk assessment (16.70%)
  • Toxicology (16.15%)

What are the most cited papers published in the journal?

  • Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). (1845 citations)
  • Concordance of the toxicity of pharmaceuticals in humans and in animals. (1333 citations)
  • A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data (738 citations)

Research areas of the most cited articles at Regulatory Toxicology and Pharmacology:

The most cited publications explore disciplines such as Toxicology, Risk assessment, Toxicity, Pharmacology and Environmental health. The journal papers facilitate discussions on Risk assessment that incorporate concepts from other fields like No-observed-adverse-effect level, Adverse effect, Hazard and Risk analysis (engineering). The published articles with studies in Toxicity featured incorporate elements of Endocrinology, Inhalation, Physiology and Carcinogen.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Enzyme
  • Cancer

The previous edition focused in particular on these issues:

Regulatory Toxicology and Pharmacology mainly tackles studies in Toxicity, Pharmacology, Risk assessment, In vivo and Risk analysis (engineering). The research on Toxicity presented in Regulatory Toxicology and Pharmacology often intersects with areas of study such as

  • Adverse effect and related No-observed-adverse-effect level,
  • Physiology, which have a strong connection to Reproductive toxicity.. While work presented in the journal provided substantial information on Pharmacology, it also covered topics in Genotoxicity and Micronucleus test.

The research on Genotoxicity featured in the journal combines topics in other fields like Ames test, Bioinformatics and Carcinogen. The featured Risk assessment studies mainly concentrate on Environmental health but also cover areas of interest in Hexavalent chromium. Among the topics covered in it are Risk analysis (engineering) and Alternative methods.

The most cited articles from the last journal are:

  • Regulatory landscape of nanotechnology and nanoplastics from a global perspective. (7 citations)
  • Ni and Cr impurities profile in Valeriana officinalis L., radix-based herbal medicinal product available in polish pharmacies due to ICH Q3D guideline. (5 citations)
  • A hazard evaluation of the reproductive/developmental toxicity of cobalt in medical devices. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Regulatory Toxicology and Pharmacology (based on the number of publications) are:

  • Michael L. Dourson (45 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Sean M. Hays (40 papers) published 1 paper at the last edition,
  • Lesa L. Aylward (34 papers) absent at the last edition,
  • Gio Batta Gori (31 papers) absent at the last edition,
  • Peter N. Lee (27 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Regulatory Toxicology and Pharmacology (based on the number of publications) are:

  • United States Environmental Protection Agency (137 papers) published 4 papers at the last edition the same number as at the previous edition,
  • Research Triangle Park (125 papers) published 7 papers at the last edition, 1 more than at the previous edition,
  • Procter & Gamble (125 papers) published 7 papers at the last edition, 3 less than at the previous edition,
  • Dow Chemical Company (110 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Pfizer (90 papers) published 8 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 19.34% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.23% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.01% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.23% of all publications and 44.52% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Impact of Regulatory Toxicology and Pharmacology on Nursing Education

The impact of the Regulatory Toxicology and Pharmacology's research work extends beyond the disciplines exclusively focused on in the journal. It's far-reaching in the healthcare domain, specifically as it pertains to nursing education. The understanding and application of toxicology and pharmacology are vital ingredients in the curriculum of nursing schools, as it prepares future nurses to deal with potential health concerns related to drugs, chemical exposure, and environmental health. Top-tier nursing schools have recognized this and have integrated knowledge imparted by journals like Regulatory Toxicology and Pharmacology into their programs. The safety, efficiency and wellbeing of patients are of paramount concern, making the inclusion of this information vital to the holistic education of student nurses. For instance, the top 10 best nursing schools in Maine have mandatory units where these topics are critically studied and applied. Through discussions on the importance of toxicity, risk assessment and pharmacology, students become well versed at anticipating the potential impacts of drugs or toxic substances on patient health and know how to manage those risks effectively. This intertwining between theoretical knowledge from research journals and its practical application in real-world settings, such as healthcare institutions, showcases the vital role of Regulatory Toxicology and Pharmacology in influencing nursing education. Whether it's understanding drug interactions, managing environmental health risks, or dealing with areas like endocrinology or genotoxicity, the journal contributes significantly to the growth and evolution of healthcare practices. Ultimately, it plays a pivotal role in enhancing the standard of healthcare provided by the nursing fraternity.

Top Publications

  • Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials

    Anne Marie Api;David Basketter;James Bridges;Peter Cadby

    (2020)
    268 Citations
  • An evaluation framework for new approach methodologies (NAMs) for human health safety assessment

    Stanley T. Parish;Michael Aschner;Warren Casey;Marco Corvaro

    (2020)
    138 Citations
  • The SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation 11th revision, 30-31 March 2021, SCCS/1628/21.

    (2021)
    116 Citations
  • Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: report of the Scientific Committee on Health, Emerging and Environmental Risks (SCHEER).

    (2021)
    85 Citations
  • Non-sugar sweeteners and cancer: Toxicological and epidemiological evidence.

    (2023)
    35 Citations
  • The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls

    (2023)
    33 Citations
  • Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation.

    Helen Prior;Paul Baldrick;Sonja Beken;Helen Booler

    (2020)
    32 Citations
  • Model systems and organisms for addressing inter- and intra-species variability in risk assessment.

    (2022)
    32 Citations
  • Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential

    Hartmut Jaeschke;F. Jay Murray;Andrew D. Monnot;David Jacobson-Kram

    (2021)
    31 Citations
  • Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen.

    Gary Eichenbaum;Kyunghee Yang;Yeshitila Gebremichael;Brett A. Howell

    (2020)
    15 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA but seeking alternative or complementary career options, several online pathways provide flexible and accessible education. For example, nurses aiming to advance their skills might explore the easiest online DNP programs, which offer convenient routes to Doctor of Nursing Practice degrees without compromising quality.

Additionally, medical professionals and administrative staff can benefit from pursuing a medical coding and billing certification. This certification opens doors to rewarding roles in healthcare management and insurance processing, combining healthcare knowledge with vital administrative skills.

For those starting their healthcare journey, the easiest nursing schools to get into provide valuable entry points. These schools offer accessible admissions criteria, enabling students to quickly enter the nursing workforce while continuing their education.

Finally, aspiring healthcare leaders can explore an accredited path through a healthcare administration degree online accredited. Accredited programs ensure the recognition and credibility required for management roles in hospitals, clinics, and other medical organizations.

Best Scientists Contributing to This Journal